Dhingra Ankur has filed 13 Form 4s with the SEC that we hold, for Summit Therapeutics Inc. (SMMT) (Chief Financial Officer), Illumina, INC. (ILMN) (SVP, Chief Financial Officer) and CareDx, Inc. (CDNA) (Chief Financial Officer). Across all of them we count 9 purchases worth $1.4M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 6,100 shares of Illumina, INC. worth $495.4K, dated 2025-05-12. The first filing on our record is dated 2021-11-29 and the latest 2026-03-09.
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-08-16 | P, purchase reported on Form 4 | 11,557 | $11.2K | 2022-08-17 |
| 2022-08-16 | P, purchase reported on Form 4 | 24,658 | $23.9K | 2023-03-08 |
| 2022-08-16 | P, purchase reported on Form 4 | 13,027 | $12.6K | 2023-03-08 |
| 2023-03-07 | P, purchase reported on Form 4 | 196,362 | $206.2K | 2023-03-08 |
| 2023-12-13 | P, purchase reported on Form 4 | 700 | $1.5K | 2023-12-13 |
| 2023-12-13 | P, purchase reported on Form 4 | 19,700 | $42.7K | 2023-12-13 |
| 2024-03-26 | P, purchase reported on Form 4 | 100,000 | $375.0K | 2024-03-27 |
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-05-12 | P, purchase reported on Form 4 | 6,100 | $495.4K | 2025-05-14 |
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-24 | P, purchase reported on Form 4 | 5,000 | $211.7K | 2021-11-29 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1849682) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms
No password to create and no card required. We store your email address and nothing else.